Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,383 | 1,381 | 98.5% |
| Education | $299.57 | 24 | 1.3% |
| Gift | $59.40 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,825 | 141 | $0 (2024) |
| Novo Nordisk Inc | $2,634 | 173 | $0 (2024) |
| Amgen Inc. | $1,569 | 110 | $0 (2024) |
| ABBVIE INC. | $1,387 | 77 | $0 (2024) |
| Lilly USA, LLC | $1,274 | 91 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,272 | 88 | $0 (2022) |
| PFIZER INC. | $1,220 | 89 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,199 | 54 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $803.42 | 29 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $799.80 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,984 | 98 | AstraZeneca Pharmaceuticals LP ($431.14) |
| 2023 | $2,352 | 112 | AstraZeneca Pharmaceuticals LP ($384.16) |
| 2022 | $2,964 | 169 | Lilly USA, LLC ($386.26) |
| 2021 | $3,696 | 195 | AbbVie Inc. ($466.33) |
| 2020 | $2,238 | 170 | Novo Nordisk Inc ($268.31) |
| 2019 | $3,643 | 231 | Novo Nordisk Inc ($671.80) |
| 2018 | $3,552 | 228 | Novo Nordisk Inc ($455.64) |
| 2017 | $3,312 | 203 | Novo Nordisk Inc ($499.20) |
All Payment Transactions
1,406 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 12/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Oncology | ||||||
| 10/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Insomnia | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 956 | 3,152 | $506,739 | $226,912 |
| 2022 | 15 | 731 | 2,698 | $405,448 | $178,934 |
| 2021 | 9 | 638 | 2,355 | $392,673 | $160,417 |
| 2020 | 12 | 757 | 2,812 | $453,237 | $173,900 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 698 | $144,723 | $57,439 | 39.7% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 139 | 521 | $91,508 | $50,242 | 54.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 555 | $114,995 | $50,100 | 43.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 142 | 623 | $50,849 | $28,856 | 56.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 73 | $29,395 | $8,874 | 30.2% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 87 | 167 | $14,719 | $8,716 | 59.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 44 | 59 | $12,489 | $5,144 | 41.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 19 | 138 | $11,435 | $4,655 | 40.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 99 | $9,598 | $3,248 | 33.8% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 65 | 69 | $8,400 | $2,993 | 35.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 13 | $8,753 | $2,669 | 30.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 15 | 80 | $5,471 | $2,328 | 42.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 21 | $2,170 | $809.76 | 37.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 23 | $1,813 | $699.20 | 38.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $421.07 | $139.23 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 730 | $151,151 | $58,341 | 38.6% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 77 | 286 | $50,233 | $28,305 | 56.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 78 | 576 | $46,997 | $27,917 | 59.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 315 | $65,268 | $24,987 | 38.3% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 49 | 153 | $13,485 | $8,091 | 60.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 49 | $19,731 | $7,426 | 37.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 27 | 196 | $16,241 | $7,070 | 43.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 25 | 167 | $16,191 | $6,115 | 37.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 33 | 48 | $10,160 | $3,871 | 38.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 19 | 106 | $7,386 | $3,233 | 43.8% |
About Dr. Hector Robles, MD
Dr. Hector Robles, MD is a Internal Medicine healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548367147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hector Robles, MD has received a total of $23,742 in payments from pharmaceutical and medical device companies, with $1,984 received in 2024. These payments were reported across 1,406 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($23,383).
As a Medicare-enrolled provider, Robles has provided services to 3,082 Medicare beneficiaries, totaling 11,017 services with total Medicare billing of $740,163. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lafayette, LA
- Active Since 09/19/2006
- Last Updated 05/12/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548367147
Products in Payments
- FARXIGA (Drug) $2,416
- Ozempic (Drug) $1,286
- JARDIANCE (Drug) $1,168
- XARELTO (Drug) $883.25
- VRAYLAR (Drug) $854.94
- Kerendia (Drug) $803.42
- Vascepa (Drug) $703.98
- ENTRESTO (Drug) $621.01
- ELIQUIS (Drug) $593.79
- UBRELVY (Drug) $551.49
- TRULICITY (Drug) $541.95
- TROKENDI XR (Drug) $470.33
- Aimovig (Biological) $438.97
- XIFAXAN (Drug) $425.52
- INVOKANA (Drug) $388.65
- Victoza (Drug) $371.49
- Tresiba (Drug) $328.97
- EVENITY (Biological) $327.21
- Sunosi (Drug) $311.46
- Yupelri (Drug) $304.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lafayette
Steven Steinhubl, Md, MD
Internal Medicine — Payments: $172,128
Dr. Eric Trawick, Md, MD
Internal Medicine — Payments: $83,507
Dr. Brent Rochon, Md, MD
Internal Medicine — Payments: $23,953
Dr. Robert Russell, Md, MD
Internal Medicine — Payments: $18,283
Nethuja Salagundla, M.d, M.D
Internal Medicine — Payments: $17,501
Dr. Maha Toma, M.d, M.D
Internal Medicine — Payments: $17,223